Cite
Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial
MLA
Inga Bekes, et al. “Quality of Life during and after Adjuvant Anthracycline-Taxane-Based Chemotherapy with or without Gemcitabine in High-Risk Early Breast Cancer: Results of the SUCCESS A Trial.” Breast Cancer Research and Treatment, vol. 175, no. 3, Oct. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e4e3fa347902c263626770b17e334287&authtype=sso&custid=ns315887.
APA
Inga Bekes, Visnja Fink, Brigitte Rack, Wolfgang Janni, Thomas W. P. Friedl, Susanne Singer, Krisztian Lato, Miriam Deniz, Peter Widschwendter, Lukas Schwentner, & Rafael J. A. Cámara. (2018). Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial. Breast Cancer Research and Treatment, 175(3).
Chicago
Inga Bekes, Visnja Fink, Brigitte Rack, Wolfgang Janni, Thomas W. P. Friedl, Susanne Singer, Krisztian Lato, et al. 2018. “Quality of Life during and after Adjuvant Anthracycline-Taxane-Based Chemotherapy with or without Gemcitabine in High-Risk Early Breast Cancer: Results of the SUCCESS A Trial.” Breast Cancer Research and Treatment 175 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e4e3fa347902c263626770b17e334287&authtype=sso&custid=ns315887.